At what enterprise value was NOVETUDE SANTE acquired in 2025?

During the acquisition of NOVETUDE SANTE by PEUGEOT INVEST in 2025, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Retail & Consumer industry currently tracks an average EBITDA multiple of 11.3x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of NOVETUDE SANTE when it was acquired by PEUGEOT INVEST?

The estimated EV/EBITDA multiple for NOVETUDE SANTE is in the range of 15x - 25x. For comparison, the Retail & Consumer sector currently shows an average EBITDA multiple of 11.3x. Join our community for free to access full valuation data and industry trends.

When was NOVETUDE SANTE acquired by PEUGEOT INVEST?

NOVETUDE SANTE was acquired by PEUGEOT INVEST in 2025.

What was the revenue of NOVETUDE SANTE at the time of the deal?

The revenue of NOVETUDE SANTE at the time of the deal is estimated to be in the range of 100M - 200M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of NOVETUDE SANTE during the acquisition?

NOVETUDE SANTE's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the NOVETUDE SANTE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the NOVETUDE SANTE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/novetude-sante-se-valorise-pres-de-750-meur-2164412

← DATABASE

Home Database Retail & ConsumerNOVETUDE SANTE

05/2025

NOVETUDE SANTE acquired by PEUGEOT INVEST

FRANCE Education / Education Providers EV 500M - 1.5b EUR

Context

Peugeot Invest and Hayfim acquires a majority stake in Novetude Sante from Latour Capital. This secondary LBO values the education group at nearly EUR750 million. Under Charterhouse's ownership, the group significantly expanded through buy-and-build strategies. With this operation Novetude aims to accelerate its European expansion (targeting countries like Spain and Italy) and diversify its training offerings in the booming healthcare education market.

Historically, the company experienced a leveraged buyout orchestrated by Charterhouse in 2020.

NOVETUDE SANTE, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Retail & Consumer sector (11.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Retail & Consumer market trends

Target

A leading French higher education group specialized in healthcare professions. It operates a network of prestigious schools (such as ESO Paris for osteopathy) and preparatory classes. The group covers a wide range of disciplines including osteopathy, nursing, and medical preparation, serving thousands of students across France.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Other operations with NOVETUDE SANTE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
11/2020	CHARTERHOUSE	NOVETUDE SANTE	FRANCE	Education	Charterhouse Capital Partners, the British private equity firm, has acquired a majority stake in Novetude Santé, a French higher education group specialized in health and well-being. The transaction marks a new partnership between two parties with a long-standing history, as Charterhouse was previously a shareholder in Elior between 2006 and 2014.

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 100M - 200M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of NOVETUDE SANTE by PEUGEOT INVEST are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: novetude sante

Acquirer: peugeot invest